Mattia Dessena
Parma, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Long-term prognostic impact of chromosome 1 abnormalities in newly diagnosed multiple myeloma patients: a monocentric study.
Journal: Annals of hematology
Published: March 11, 2026
PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progression.
Journal: Cancer gene therapy
Published: November 27, 2025
Oncolytic bovine herpesvirus type 1 induces immune microenvironment remodeling and enhances treatment responses in multiple myeloma.
Journal: Haematologica
Published: September 30, 2025
High glutamate levels in the bone marrow of multiple myeloma patients promote osteoclast formation: a novel target for osteolytic bone disease.
Journal: Leukemia
Published: January 28, 2025
Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients.
Journal: Frontiers in immunology
Published: November 22, 2024
Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients.
Journal: Frontiers in immunology
Published: August 20, 2024
In vitro evaluation of the immunomodulatory activity of the nutraceutical formulation AminoDefence.
Journal: International journal of food sciences and nutrition
Published: November 29, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026